Navigation Links
Former Singapore EDB Officer, Chew Hwee Yong, Joins Menicon as Chief of Special Projects as Menicon Accelerates its Globalization
Date:8/31/2010

NAGOYA, Japan, Sept. 1 /PRNewswire/ -- Menicon Co., Ltd. (Menicon) announced the appointment of Chew Hwee Yong as Chief of Special Projects at the company's head office in Nagoya, Japan. Chew, to be based in Nagoya, will be responsible for updating and expanding Menicon's internal processes as well as external relations to support the company's globalization.

Chew started his career with the Singapore Economic Development Board (EDB). During his nine-year tenure with the EDB, Chew was responsible for overseeing significant projects in different high-tech industries (precision engineering, electronics and information/communications & media clusters). Chew also spent three years in Osaka, Japan, as the EDB's Centre Director covering western Japan and attracted investments from diverse fields including electronics, biomedical sciences, precision engineering, chemicals, food and water treatment.

While stationed in Japan from 2006 to 2009, Chew also served as a Consul at the Consulate-General Office of the Republic of Singapore, Osaka. During his term, he was the representative for Singaporeans in western Japan and fostered strong relationships with the western Japan industrial community.

Chew has a Bachelor of Engineering degree in Precision Engineering from the University of Tokyo and a Master of Engineering degree in Optics & Optoelectronics, Electrical Engineering, from Princeton University. He is proficient in English, Chinese and Japanese.

"I am very excited about joining the Menicon team," said Chew. "Menicon has made several key acquisitions in recent years and is developing new products leveraging on our strength as a technology company. Coming in at a very exciting and crucial point in Menicon's corporate history, I want to do my best to contribute to building Menicon into a global enterprise."

"We are very pleased to welcome Mr. Chew to Menicon as he will be able to bring considerable skill and knowledge necessary to building Menicon's global operations infrastructure," said Toshio Matsushima, Head of Global Strategy at Menicon.  

About Menicon:

Menicon Co. (www.menicon.com), founded by Kyoichi Tanaka in 1951, is Japan's first and largest contact lens manufacturer, and now is represented in over 30 countries. Menicon is a manufacturer dedicated to all areas of soft and GP contact lens-related businesses including material development, lens designing, and manufacturing of contact lenses and care solutions. Menicon is a world leader in the development of hyper-Dk GP (Menicon Z) and soft contact lenses (Menicon PremiO).  Contact: Toshio MatsushimaGlobal Strategies & OperationsMenicon Co., Ltd.Phone: +81-52-937-5021Fax: +81-52-935-1121E-mail: matsushima@menicon-net.co.jp URL: http://www.menicon.com
'/>"/>

SOURCE Menicon Co., Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
2. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
3. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
4. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
5. Michigan Life Science and Innovation Center Opens in Former Pfizer Facility
6. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
7. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
8. Former Miss USA Shawnae Jebbia Shines with Siemens Pure
9. Secure eHealth, LLC Engages as a Consultant GSI Health Whose Principal and CEO is the Former Senior Advisor to National Coordinator for Health Information Technology
10. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
11. SCAI Statement on the Hospitalization of Former President Bill Clinton
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):